Back to Search Start Over

[Human Papillomavirus: screening of cervical and anal cancers].

Authors :
Pache B
Jacot-Guillarmod M
Hübner M
Mathevet P
Source :
Revue medicale suisse [Rev Med Suisse] 2022 Oct 19; Vol. 18 (800), pp. 1950-1955.
Publication Year :
2022

Abstract

Cervical cancer is preventable through primary and secondary prevention. Vaccination against the human papillomavirus (HPV), the virus necessary for the development of precancerous lesions, can prevent most of them. Screening by cytology for these precancerous (or cancerous) lesions can be replaced by screening for certain types of HPV, high risk (HR-HPV), causing cervical cancer. The presence of HR-HPV on the cervix should raise suspicion of concomitant infection in the anus, as both epithelia are highly susceptible. This attitude is dictated by the increase incidence in anal cancer in the population, which is also HPV-dependent and therefore also potentially preventable through vaccination and screening.<br />Competing Interests: La Dre Martine Jacot-Guillarmod est membre du comité consultatif sur la vaccination HPV chez MSD. L’entier des honoraires est reversé au CHUV. Les autres auteurs n’ont déclaré aucun conflit d’intérêts en relation avec cet article.

Details

Language :
French
ISSN :
1660-9379
Volume :
18
Issue :
800
Database :
MEDLINE
Journal :
Revue medicale suisse
Publication Type :
Academic Journal
Accession number :
36259700
Full Text :
https://doi.org/10.53738/REVMED.2022.18.800.1950